載入...

An osteopontin/CD44 immune checkpoint controls CD8(+) T cell activation and tumor immune evasion

Despite breakthroughs in immune checkpoint inhibitor (ICI) immunotherapy, not all human cancers respond to ICI immunotherapy and a large fraction of patients with the responsive types of cancers do not respond to current ICI immunotherapy. This clinical conundrum suggests that additional immune chec...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Clin Invest
Main Authors: Klement, John D., Paschall, Amy V., Redd, Priscilla S., Ibrahim, Mohammed L., Lu, Chunwan, Yang, Dafeng, Celis, Esteban, Abrams, Scott I., Ozato, Keiko, Liu, Kebin
格式: Artigo
語言:Inglês
出版: American Society for Clinical Investigation 2018
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6264631/
https://ncbi.nlm.nih.gov/pubmed/30395540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI123360
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!